We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
Roco, M. C. and Montemagno, C., “Preface,”The Coevolution of Human Potential and Converging Technologies, Roco, M. C. and Montemagno, C. eds. (New York: The New York Academy of Sciences, 2004): At vii.Google Scholar
2
Roco, M. C., “Science and Technology Integration for Increased Human Potential and Societal Outcomes,”The Coevolution of Human Potential and Converging Technologies, Roco, M. C. and Montemagno, C. eds. (New York: The New York Academy of Sciences2004): At 1, 2.Google Scholar
See Mazzola, L., “Commercializing Nanotechnology”Nature Biotechnology21 (2003): 1137–1143.CrossRefGoogle Scholar
9
Wolbring, G., “Future Shock? Flagging NBIC Technologies,”Financial Flows for Health Research28 (Geneva Switzerland: Global Forum for Health Research, 2004).Google Scholar
10
Bond, P. J., “Vision for Converging Technologies and Future Society,”The Coevolution of Human Potential and Converging Technologies, Roco, M. C. and Montemagno, C. eds. (New York: Annals of the New York Academy of Sciences, 2004): 17–20.Google Scholar
11
Gorman, M. E., “Collaborating on Convergent Technologies: Education and Practice,”The Coevolution of Human Potential and Converging Technologies, Roco, M. C. and Montemagno, C. eds. (New York: Annals of the New York Academy of Sciences, 2004): At 25.Google Scholar
12
Miller, S. E., “How the Legal System Should Change as a Result of Converging Technologies,”The Coevolution of Human Potential and Converging Technologies, Roco, M. C. and Montemagno, C. eds. (New York: Annals of the New York Academy of Sciences, 2004): 178.Google Scholar
See, e.g., Wejnert, J., “Regulatory Mechanisms for Molecular Nanotechnology,”Jurimetrics Journal44 (2004): 323–330.Google Scholar
17
See, e.g., Miller, J., “Beyond Biotechnology: FDA Regulation of Nanomedicine,”Columbia Science & Technical Law Review44 (2004): 1–33; see also, Fiedler, F. A. and Reynolds, G. H., “Legal Problems of Nanotechnology: An Overview,” Southern California Interdisciplinary Law Journal 3 (1994): 593–617, at 607–612.Google Scholar